andrew myers chemistry
Andrew Myers and Harvard Sued by Former PhD Student. Dr. Mark Charest, a chemistry PhD student who graduated from Harvard in 2004, is suing the university and Andrew Myers, his PhD advisor, over the royalties associated with a patent covering intellectual property developed during Charest’s graduate work. Myers, the Amory Houghton professor of chemistry and chemical biology at Harvard, wouldn’t discuss the allocation of royalties, referring questions to the university. But he said he was pleased that Woodlock had dismissed the charges against him. Leveraging the rich biotech ecosystem in Massachusetts. Building on pioneering research performed at the Myers chemistry lab at Harvard University, we are now advancing several lead candidates into preclinical development programs at our laboratories in Watertown, Massachusetts, USA. By Madeline R. Conway, CRIMSON STAFF WRITER July 4, 2013. Mark G. Charest, a former Harvard Ph.D. student, has filed a lawsuit against the University and chemistry and chemical biology professor Andrew G. Myers, seeking an estimated $10 million as compensation for alleged breach of contract and fraud, among other allegations. 07/29/2009. Dr. Andrew Myers. Pittsburg State University has hired a new director to oversee its Kansas Polymer Research Center and Business and Technology Institute. Dr. Andrew Myers, a scientist and project manager with TDA Research, Inc., a Colorado-based chemistry and engineering research company, will begin his new appointment Aug. 12. The case focuses on Harvard professor Andrew G. Myers’s chemistry lab, which discovered a method for synthetically creating a new class of tetracycline antibiotics and licensed its technology to Watertown’s Tetraphase Pharmaceuticals Inc. Former graduate student Mark Charest, who worked in the lab and was lead author of a paper describing the discovery in the journal Science, filed suit against Harvard and Myers in 2013. His lawsuit alleged, among other things, that he was cheated out of patent royalties worth about $10 million. Suit alleges breach of contract and fraud following antibiotics discovery. Mark G. Charest, a former Harvard Ph.D. student, has filed a lawsuit against the University and chemistry and chemical biology professor Andrew G. Myers, seeking an estimated $10 million as compensation for alleged breach of contract and fraud, among other allegations. Andrew Myers and Harvard Sued by Former PhD Student. June 30th, 2013. Dr. Mark Charest, a chemistry PhD student who graduated from Harvard in 2004, is suing the university and Andrew Myers, his PhD advisor, over the royalties associated with a patent covering intellectual property developed during Charest’s graduate work. To achieve our objectives, the Macrolide Pharmaceuticals team of drug development experts utilizes groundbreaking synthetic chemistry initially developed by Professor Andrew Myers at Harvard University. The company was founded in 2015.
The Macrolide Pharmaceuticals team of drug development experts utilizes groundbreaking synthetic chemistry initially developed by Professor Andrew Myers at Harvard University.